MedTrace Logo

Mhealth and Teach-Back Effectiveness In 30-Day Readmissions Reduction

NCT04738669 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2021-02-10

No results posted yet for this study

Summary

The Study is a feasibility randomized controlled trial aiming to assess the feasibility of mHealth (voice call and SMS) and teach-back interventions on reducing the 30 days readmission rate in the patients enrolled in the Sehat Sahulat Programme (Prime Minister National Health Programme(PMNHP)).

The prime objective of this study was to generate a proof of concept for the conduct of a definitive trial for the reduction in readmissions in PMNHP.

A feasibility randomized controlled trial study consisted of three arms i.e intervention 1 (telephonic contact and text messages), intervention 2 (teach-back method) and control is planned in program beneficiaries of Islamabad, Pakistan.

The trial is being carried out in the three hospitals of Islamabad and patients are being recruited as per the inclusion and exclusion criteria.

Conditions

  • Readmission
  • mHealth
  • Teach-Back Communication

Interventions

OTHER

mHealth

The mHealth intervention includes telephonic call and SMS.

BEHAVIORAL

Teach-back

While the teach-back includes counselling session related to discharge instruction including medication adherence.

Sponsors & Collaborators

  • Health Services Academy, Islamabad, Pakistan

    lead OTHER

Principal Investigators

  • Assad Hafeez, PhD · Health Services Academy, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-03-31
Completion
2021-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04738669 on ClinicalTrials.gov